Publication View

Poly-gamma-Glutamate Capsule-Degrading Enzyme Treatment Enhances Phagocytosis and Killing of Encapsulated Bacillus Anthracis (2007)

Abstract
The poly gamma-D-glutamic acid capsule confers antiphagocytic properties on Bacillus anthracis and is essential for virulence. In this study, we showed that two recombinant glutamylases: CapD, a gamma-polyglutamic acid depolymerase encoded on the B. anthracis capsule plasmid, and PghP, a gamma-polyglutamic acid hydrolase encoded by bacteriophage Phi, NIT1, degraded purified capsule and removed the capsule from the surface of anthrax bacilli. Treatment with CapD or PghP induced macrophage phagocytosis of encapsulated B. anthracis. Additionally, enzyme treatment enabled human neutrophils to kill encapsulated organisms. The levels of both phagocytosis and killing corresponded to the degree of capsule degradation; CapD was more effective than PghP.. Pub. in Antimicrobial Agent and Chemotherapy,v51 n1, p215-222, Jan 2007.

Publication details
Download http://handle.dtic.mil/100.2/ADA460058
Contributors ARMY MEDICAL RESEARCH INST OF INFECTIOUS DISEASES FORT DETRICK MD
Repository Defense Technical Information Center OAI-PMH Repository (United States)
Keywords MEDICINE AND MEDICAL RESEARCH, MICROBIOLOGY, *ANTHRAX, *PHAGOCYTES, *POLYMORPHONUCLEAR NEUTROPHILS, *BACTERIOPHAGES, *BACILLUS ANTHRACIS, KILL PROBABILITIES, HUMANS, CAPSULES(PHARMACY), VIRULENCE, RETICULOENDOTHELIAL SYSTEM, MACROPHAGES, ENZYMES, ENCAPSULATION, *GLUTAMATE-DEGRADING ENZYMES, *POLY-GAMMA-GULTAMATE, CAPSULE, ANTIPHAGOCYTIC
Language eng